Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Website Tools
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Partnering With NIAID

Addressing complex public health issues requires the combined efforts of government agencies, academic institu​tions, private-sector companies, and nonprofit organizations. Such partnerships help leverage resources, improve efficiency and cost-effectiveness, and increase the feasibility and scientific impact of the research. NIAID has a successful collaborative track record and continues to promote partnerships with domestic and international entities to advance research on infectious and immunologic diseases; to develop and test new methods of prevention, diagnosis, and treatment; and to accelerate the translation of research findings into medical products.

NIAID brings to each partnership a clearly articulated research mission; access to outstanding scientific expertise and resources, such as specimen repositories; competitive funding opportunities for research and research training; and opportunities to collaborate with scientists in NIAID laboratories.

NIAID partners typically contribute funds, expertise, and/or other resources that complement NIAID research efforts. Partners also may engage in project planning and implementation; contribute staff and research capacity; facilitate access to patient volunteers and other study populations; provide administrative, logistical, and clinical resources; and particularly in foreign countries, serve as liaisons to regional, national, and local government agencies and other organizations.

Elements of a Successful Partnership

  • Shared scientific mission, interests, principles, standards, and leadership
  • Excellence in research conducted according to the highest ethical standards
  • Mutually defined goals and objectives for collaboration
  • Responsiveness to public health and medical needs and priorities
  • Agreement from the beginning on the contributions and expectations of all partners
  • Clear understanding of the study aims, benefits, and public health impact of the research collaboration for all stakeholders and study populations
  • Transparency and accountability
  • An environment of collegiality, trust, and respect
  • Ongoing and open communication, coordination, and integration of activities
  • Efficient and effective use of resources

Additional Information

  • Resources for researchers
    Includes funding opportunities, research tools and technologies, preclinical and clinical services, training, databases, and repositories related to infectious and immunologic diseases

Last Updated March 23, 2011

Last Reviewed October 18, 2010